267 related articles for article (PubMed ID: 28801060)
1. Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).
Gillanders SL; O'Neill JP
Eur J Surg Oncol; 2018 Mar; 44(3):286-296. PubMed ID: 28801060
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.
Xu B; Ghossein R
Eur J Surg Oncol; 2018 Mar; 44(3):338-347. PubMed ID: 28554832
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
10. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Lim J; Kwon JS; Vriens MR; Clark OH; Shen WT; Gosnell JE; Suh I; Duh QY
Thyroid; 2016 Jun; 26(6):820-4. PubMed ID: 27083216
[TBL] [Abstract][Full Text] [Related]
11. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
13. Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer.
Yan H; Winchester DJ; Prinz RA; Wang CH; Nakazato Y; Moo-Young TA
Ann Surg Oncol; 2018 Oct; 25(11):3193-3199. PubMed ID: 30039325
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.
Qiu ZL; Shen CT; Sun ZK; Song HJ; Xi C; Zhang GQ; Wang Y; Luo QY
Front Endocrinol (Lausanne); 2020; 11():588024. PubMed ID: 33716950
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
Wreesmann VB; Nixon IJ; Rivera M; Katabi N; Palmer F; Ganly I; Shaha AR; Tuttle RM; Shah JP; Patel SG; Ghossein RA
Thyroid; 2015 May; 25(5):503-8. PubMed ID: 25748079
[TBL] [Abstract][Full Text] [Related]
16. Risk group-based management of differentiated thyroid carcinoma.
Kuriakose MA; Hicks WL; Loree TR; Yee H
J R Coll Surg Edinb; 2001 Aug; 46(4):216-23. PubMed ID: 11523714
[TBL] [Abstract][Full Text] [Related]
17. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
18. [Anatomo-pathology and histological prognosis of follicular thyroid carcinoma].
de Micco C
Ann Endocrinol (Paris); 1997; 58(3):172-82. PubMed ID: 9239238
[TBL] [Abstract][Full Text] [Related]
19. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
20. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
Nilubol N; Zhang L; Kebebew E
Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]